Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amphastar Pharmaceuticals (AMPH) Return on Sales: 2012-2024

Historic Return on Sales for Amphastar Pharmaceuticals (AMPH) over the last 13 years, with Dec 2024 value amounting to 0.20%.

  • Amphastar Pharmaceuticals' Return on Sales fell 8.00% to 0.14% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.14%, marking a year-over-year decrease of 8.00%. This contributed to the annual value of 0.20% for FY2024, which is 1.00% down from last year.
  • According to the latest figures from FY2024, Amphastar Pharmaceuticals' Return on Sales is 0.20%, which was down 4.12% from 0.21% recorded in FY2023.
  • In the past 5 years, Amphastar Pharmaceuticals' Return on Sales registered a high of 0.21% during FY2023, and its lowest value of 0.00% during FY2020.
  • Moreover, its 3-year median value for Return on Sales was 0.20% (2024), whereas its average is 0.20%.
  • Its Return on Sales has fluctuated over the past 5 years, first decreased by 19bps in 2020, then grew by 14bps in 2021.
  • Yearly analysis of 5 years shows Amphastar Pharmaceuticals' Return on Sales stood at 0.00% in 2020, then climbed by 14bps to 0.15% in 2021, then grew by 3bps to 0.18% in 2022, then grew by 4bps to 0.21% in 2023, then declined by 1bps to 0.20% in 2024.